In a no-deal Brexit, supply chains for products sourced from the European Union and European Economic Area (EEA) may be affected by changes to border processes and procedures.
Pharmaceutical companies have been contingency planning to ensure continuity of supply. These measures include building stockpiles and using air freight to avoid any border delays.
The shipment of medicines by air freight requires specific control measures. This guidance provides advice on Good Distribution Practice (GDP) requirements for air freight to ensure that product quality and security is protected.